Comparative study of a point-of-care test and an enzyme-linked immunosorbent assay (ELISA) for infliximab levels-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparative study of a point-of-care test and an enzyme-linked immunosorbent assay (ELISA) for infliximab levels

Published:2023-10-26 Issue:2 Volume:59 Page:150-155
ISSN:0036-5521
Container-title:Scandinavian Journal of Gastroenterology
language:en
Short-container-title:Scandinavian Journal of Gastroenterology

Author:

Thunberg Joel¹^ORCID,Grännö Olle²^ORCID,Bergemalm Daniel¹,Eriksson Carl¹³^ORCID,Visuri Isabella¹^ORCID,Eberhardson Michael⁴⁵,Halfvarson Jonas¹^ORCID

Affiliation:

1. Department of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden

2. Department of Laboratory Medicine, Clinical Microbiology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden

3. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden

4. Department of Gastroenterology and Hepatology, Linköping University Hospital, Linköping, Sweden

5. Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden

Funder

Regional Agreement on Medical Training and Clinical Research between Region Örebro County and Örebro University: ALF from Örebro Region County

Swedish Foundation for Strategic Research

ProciseDx

Publisher

Informa UK Limited

Subject

Gastroenterology

Link

https://www.tandfonline.com/doi/pdf/10.1080/00365521.2023.2269456

Reference29 articles.

1. Loss of Response to Anti-TNFs: Definition, Epidemiology, and Management

2. Systematic Review and Meta-analysis: Loss of Response and Need for Dose Escalation of Infliximab and Adalimumab in Ulcerative Colitis

3. Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study

4. Therapeutic drug monitoring of biologics in inflammatory bowel disease: unmet needs and future perspectives

5. Therapeutic drug monitoring in inflammatory bowel disease: implementation, utilization, and barriers in clinical practice in Scandinavia

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3